Propranolol treatment for subglottic haemangioma

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 96, Issue 4, 2011, Pages

  Guye, E ^a   Chollet Rivier, M ^a   Schroder D ^a   Sandu, K ^a   Hohlfeld, J ^a   De Buys Roessingh, A ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PROPRANOLOL;

ABSENCE OF SIDE EFFECTS; ARTICLE; BREAST FEEDING; DRUG EFFICACY; DRUG TOLERANCE; DYSPNEA; ENDOSCOPY; HOSPITAL ADMISSION; HUMAN; INFANT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SKIN HEMANGIOMA; STRIDOR; SUBGLOTTIC HEMANGIOMA; TREATMENT RESPONSE;

ADRENERGIC BETA-ANTAGONISTS; HEMANGIOMA; HUMANS; INFANT; LARYNGEAL NEOPLASMS; LARYNGOSCOPY; LARYNGOSTENOSIS; LIP NEOPLASMS; MALE; PROPRANOLOL;

EID: 79959832873     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2010.201905     Document Type: Article

References (4)

1. Jang YC, Arumugam S, Ferguson M, et al. Changes in matrix composition during the growth and regression of human haemangiomas. J Surg Res 1998;80:9-15. (Pubitemid 28507632)
2. Drolet BA, Esterly NB, Frieden IJ. Haemangiomas in children. N Engl J Med 1999;341:173-81.
3. Greinwald JH Jr, Burke DK, Bonthius DJ, et al. An update on the treatment of haemangiomas in children with interferon alfa-2a. Arch Otolaryngol Head Neck Surg 1999;125:21-7. (Pubitemid 29074891)
4. Denoyelle F, Leboulanger N, Enjolras O, et al. Role of Propranolol in the therapeutic strategy of infantile laryngotracheal haemangioma. Int J Pediatr Otorhinolaryngol 2009;73:1168-72.